Insulin Action in the Double Incretin Receptor Knockout Mouse

  1. Julio E. Ayala1,
  2. Deanna P. Bracy1,
  3. Tanya Hansotia2,
  4. Grace Flock2,
  5. Yutaka Seino3,
  6. David H. Wasserman1 and
  7. Daniel J. Drucker2
  1. 1Department of Molecular Physiology and Biophysics and National Institutes of Health Mouse Metabolic Phenotyping Center, Vanderbilt University School of Medicine, Nashville, Tennessee
  2. 2Banting and Best Diabetes Centre, Departments of Medicine and Laboratory Medicine and Pathobiology, Samuel Lunenfeld Research Institute, Mount Sinai Hospital, University of Toronto, Toronto, Ontario, Canada
  3. 3Kansai Electric Power Hospital, Osaka, Japan
  1. Address correspondence and reprint requests to Julio E. Ayala, PhD, Vanderbilt University Medical Center, 2200 Pierce Ave., 702 Light Hall, Nashville, TN 37232. E-mail: julio.ayala{at}vanderbilt.edu

Abstract

OBJECTIVE—The incretins glucagon-like peptide 1 and glucose-dependent insulinotropic polypeptide have been postulated to play a role in regulating insulin action, although the mechanisms behind this relationship remain obscure. We used the hyperinsulinemic-euglycemic clamp to determine sites where insulin action may be modulated in double incretin receptor knockout (DIRKO) mice, which lack endogenous incretin action.

RESEARCH DESIGN AND METHODS—DIRKO and wild-type mice were fed regular chow or high-fat diet for 4 months. Clamps were performed on 5-h–fasted, conscious, unrestrained mice using an arterial catheter for sampling.

RESULTS—Compared with wild-type mice, chow and high fat–fed DIRKO mice exhibited decreased fat and muscle mass associated with increased energy expenditure and ambulatory activity. Clamp rates of glucose infusion (GIR), endogenous glucose production (endoRa), and disappearance (Rd) were not different in chow-fed wild-type and DIRKO mice, although insulin levels were lower in DIRKO mice. Liver Akt expression was decreased but Akt activation was increased in chow-fed DIRKO compared with wild-type mice. High-fat feeding resulted in fasting hyperinsulinemia and hyperglycemia in wild-type but not in DIRKO mice. GIR, suppression of endoRa, and stimulation of Rd were inhibited in high fat–fed wild-type mice but not in DIRKO mice. High-fat feeding resulted in impaired tissue glucose uptake (Rg) in skeletal muscle of wild-type mice but not of DIRKO mice. Liver and muscle Akt activation was enhanced in high fat–fed DIRKO compared with wild-type mice.

CONCLUSIONS—In summary, DIRKO mice exhibit enhanced insulin action compared with wild-type mice when fed a regular chow diet and are protected from high-fat diet–induced obesity and insulin resistance.

Footnotes

  • Published ahead of print at http://diabetes.diabetesjournals.org on 31 October 2007. DOI: 10.2337/db07-0704.

  • 2[14C]DG, 2[14C]deoxyglucose; 2[14C]DGP, 2[14C]deoxyglucose-6-phosphate; DIRKO, double incretin receptor knockout; endoRa, endogenous glucose production; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; GIP, glucose-dependent insulinotropic polypeptide; GIPR, G-protein–coupled receptor for GIP; GIR, glucose infusion rate; GLP-1, glucagon-like peptide 1; GLP-1R, G-protein–coupled receptor for GLP-1; LBM, lean body mass; NEFA, nonesterified fatty acid; RER, respiratory exchange ratio; SVL, superficial vastus lateralis.

  • The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

    • Accepted October 26, 2007.
    • Received May 25, 2007.
« Previous | Next Article »Table of Contents